| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |